- Home
- TDTH vs GLYC Comparison
TDTH vs GLYC Comparison
Compare TDTH & GLYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDTH
- GLYC
- Stock Information
- Founded
- TDTH 2014
- GLYC 2003
- Country
- TDTH Singapore
- GLYC United States
- Employees
- TDTH N/A
- GLYC N/A
- Industry
- TDTH
- GLYC Biotechnology: Pharmaceutical Preparations
- Sector
- TDTH
- GLYC Health Care
- Exchange
- TDTH NYSE
- GLYC Nasdaq
- Market Cap
- TDTH 17.2M
- GLYC 16.2M
- IPO Year
- TDTH 2024
- GLYC 2014
- Fundamental
- Price
- TDTH $0.24
- GLYC N/A
- Analyst Decision
- TDTH
- GLYC Hold
- Analyst Count
- TDTH 0
- GLYC 3
- Target Price
- TDTH N/A
- GLYC N/A
- AVG Volume (30 Days)
- TDTH 9.1M
- GLYC 5.0M
- Earning Date
- TDTH 07-01-2025
- GLYC 08-08-2025
- Dividend Yield
- TDTH N/A
- GLYC N/A
- EPS Growth
- TDTH N/A
- GLYC N/A
- EPS
- TDTH N/A
- GLYC N/A
- Revenue
- TDTH $465,435.00
- GLYC N/A
- Revenue This Year
- TDTH N/A
- GLYC N/A
- Revenue Next Year
- TDTH N/A
- GLYC N/A
- P/E Ratio
- TDTH N/A
- GLYC N/A
- Revenue Growth
- TDTH N/A
- GLYC N/A
- 52 Week Low
- TDTH $0.17
- GLYC $0.14
- 52 Week High
- TDTH $4.74
- GLYC $0.63
- Technical
- Relative Strength Index (RSI)
- TDTH N/A
- GLYC 9.01
- Support Level
- TDTH N/A
- GLYC $15.15
- Resistance Level
- TDTH N/A
- GLYC $17.91
- Average True Range (ATR)
- TDTH 0.00
- GLYC 1.47
- MACD
- TDTH 0.00
- GLYC -2.25
- Stochastic Oscillator
- TDTH 0.00
- GLYC 0.00
About TDTH TRIDENT DIGITAL TECH HOLDINGS LTD SPON ADS EACH REP 8 ORD CL B
Trident Digital Tech Holdings Ltd is principally engaged in the provision of business consulting service and IT customization solutions in the Republic of Singapore. Its revenue is derived from business consulting service, IT customization and selling event tickets.
About GLYC GlycoMimetics Inc.
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.